Exploring Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumors Treatment

Exploring the efficacy of medications like imatinib, sunitinib, and ripretinib in GIST treatment based on clinical trials and tumor genotyping. The chapter emphasizes dosage adjustments and outcomes for different gene mutations, reflecting the dynamic nature of targeted therapy in GIST.